Toshiko Motoji

3.5k total citations · 1 hit paper
121 papers, 2.6k citations indexed

About

Toshiko Motoji is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Toshiko Motoji has authored 121 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 36 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Toshiko Motoji's work include Acute Myeloid Leukemia Research (44 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Lymphoma Diagnosis and Treatment (20 papers). Toshiko Motoji is often cited by papers focused on Acute Myeloid Leukemia Research (44 papers), Chronic Lymphocytic Leukemia Research (24 papers) and Lymphoma Diagnosis and Treatment (20 papers). Toshiko Motoji collaborates with scholars based in Japan, Pakistan and Russia. Toshiko Motoji's co-authors include Kazuo Oshimi, Minoko Takanashi, Hideaki Mizoguchi, Osamu Yamada, Norio Asou, Hideaki Mizoguchi, Hitoshi Kiyoi, Shuichi Miyawaki, Kenji Saito and Hidehiko Saito and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Toshiko Motoji

116 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

1999 620 citations Norio Asou, Toshiko Motoji et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshiko Motoji Japan	26	1.5k	915	700	578	399	121	2.6k
Marie‐Thérèse Daniel France	30	1.4k 0.9×	1.2k 1.3×	499 0.7×	818 1.4×	400 1.0×	58	2.8k
Dario Ferrero Italy	25	1.0k 0.7×	872 1.0×	488 0.7×	472 0.8×	338 0.8×	92	2.0k
Christine Arnoulet France	28	1.6k 1.0×	885 1.0×	702 1.0×	624 1.1×	809 2.0×	69	2.6k
MM Le Beau United States	31	1.9k 1.3×	1.3k 1.4×	733 1.0×	409 0.7×	290 0.7×	54	3.1k
Rajko Kušec Croatia	24	1.0k 0.7×	979 1.1×	887 1.3×	280 0.5×	219 0.5×	104	2.0k
Anna Porwit‐MacDonald Sweden	30	1.1k 0.7×	610 0.7×	631 0.9×	604 1.0×	436 1.1×	50	2.7k
Danielle Sainty France	25	1.7k 1.1×	1.2k 1.3×	578 0.8×	623 1.1×	1.2k 2.9×	74	3.0k
Fumio Bessho Japan	29	1.1k 0.7×	863 0.9×	286 0.4×	357 0.6×	230 0.6×	102	2.4k
Hélène A. Poirel Belgium	23	778 0.5×	804 0.9×	637 0.9×	674 1.2×	351 0.9×	56	2.1k
Mario Sessarego Italy	28	1.8k 1.2×	425 0.5×	882 1.3×	387 0.7×	316 0.8×	122	2.3k

Countries citing papers authored by Toshiko Motoji

Since Specialization

Citations

This map shows the geographic impact of Toshiko Motoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiko Motoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiko Motoji more than expected).

Fields of papers citing papers by Toshiko Motoji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiko Motoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiko Motoji. The network helps show where Toshiko Motoji may publish in the future.

Co-authorship network of co-authors of Toshiko Motoji

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiko Motoji. A scholar is included among the top collaborators of Toshiko Motoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiko Motoji. Toshiko Motoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imai, Yoichi, Michihiko Masuda, Shigeru Hoshino, et al.. (2014). Prospective Analysis of Cytomegalovirus Reactivation and the Immune State of Low-Grade B-Cell Lymphoma Patients Treated with Bendamustine. Blood. 124(21). 4411–4411. 2 indexed citations

Mori, Naoki, Kentaro Yoshinaga, Masanao Teramura, et al.. (2013). L265P Mutation of the MYD88 Gene Is Frequent in Waldenström’s Macroglobulinemia and Its Absence in Myeloma. PLoS ONE. 8(11). e80088–e80088. 25 indexed citations

Takanashi, Minoko, Takeshi Odajima, Kentaro Yoshinaga, et al.. (2012). Risk factor analysis of vasovagal reaction from blood donation. Transfusion and Apheresis Science. 47(3). 319–325. 52 indexed citations

Kobayashi, Yukio, Hisashi Sakamaki, Shin Fujisawa, et al.. (2011). Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis. International Journal of Hematology. 93(6). 745–749. 7 indexed citations

Wang, Yanhua, et al.. (2011). Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells. Leukemia Research. 35(9). 1219–1225. 30 indexed citations

Kitagawa, Yukiko, Yuichi Sameshima, Akihiro Masuda, et al.. (2008). Isolated granulocytic sarcoma of the small intestine successfully treated with chemotherapy and bone marrow transplantation. International Journal of Hematology. 87(4). 410–413. 23 indexed citations

Mori, Naoki, et al.. (2007). [Recombinant factor VIII-CVP therapy for acquired factor VIII inhibitors].. PubMed. 48(7). 581–5. 1 indexed citations

Wang, Yanhua, et al.. (2006). Multidrug resistance protein expression of adult T-cell leukemia/lymphoma. Leukemia Research. 31(4). 465–470. 11 indexed citations

Matsuno, Naofumi, Motomi Osato, Naoto Yamashita, et al.. (2003). Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype. Leukemia. 17(12). 2492–2499. 43 indexed citations

10.

Motoji, Toshiko, et al.. (2003). Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line. Cancer Letters. 199(1). 61–68. 24 indexed citations

11.

Higaki, Yuko, et al.. (2003). Cutaneous Granulomas Associated with Adult T-Cell Leukemia/Lymphoma. Dermatology. 206(2). 157–160. 16 indexed citations

12.

Yoshinaga, Kentaro, Masanao Teramura, Shoko Kobayashi, et al.. (2001). Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma. American Journal of Hematology. 66(3). 220–223. 6 indexed citations

13.

Motoji, Toshiko, et al.. (2000). Multidrug resistance of acute leukemia and a strategy to overcome it.. PubMed. 72(4). 418–24. 14 indexed citations

14.

Motoji, Toshiko, Isamu Sugawara, Yanhua Wang, et al.. (2000). Significance of lung resistance‐related protein in the clinical outcome of acute leukaemic patients with reference to P‐glycoprotein. British Journal of Haematology. 110(2). 370–378. 14 indexed citations

15.

Okada, Michiko, et al.. (1999). Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome. British Journal of Haematology. 105(3). 844–845. 7 indexed citations

16.

Yamada, Osamu, Toshiko Motoji, & Hideaki Mizoguchi. (1996). Up-regulation of telomerase activity in human lymphocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1314(3). 260–266. 63 indexed citations

17.

Motoji, Toshiko, et al.. (1996). Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia. British Journal of Haematology. 94(3). 513–516. 23 indexed citations

18.

Yamada, Osamu, Kazuo Oshimi, Toshiko Motoji, & Hideaki Mizoguchi. (1995). Telomeric DNA in normal and leukemic blood cells.. Journal of Clinical Investigation. 95(3). 1117–1123. 48 indexed citations

19.

Masuda, M, Yukari Arai, Masatake Osawa, et al.. (1993). Heterogeneity of CD7+ 4- 8- 1- leukemia: usefulness of cytoplasmic antigen detection for subclassification.. PubMed. 7(11). 1759–65. 3 indexed citations

20.

Mori, Shigeo, et al.. (1985). Neoplastic angioendotheliosis with B lymphocyte markers on neoplastic cells: a case report.. PubMed. 76(3). 208–12. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact